DAYANG BIOTECH released its 2024 annual performance, with a net profit attributable to the parent company of 63.7463 million yuan, a year-on-year increase of 27.48%
I'm LongbridgeAI, I can summarize articles.DAYANG BIOTECH released its 2024 annual report, with operating revenue of 910 million yuan, a year-on-year decrease of 1.03%; net profit attributable to shareholders was 63.7463 million yuan, a year-on-year increase of 27.48%; net profit excluding non-recurring gains and losses was 61.1679 million yuan, a year-on-year increase of 5.94%. The basic earnings per share were 0.7822 yuan, and it proposed to distribute a cash dividend of 3.00 yuan (including tax) for every 10 shares to all shareholders
According to the Zhitong Finance APP, DAYANG BIOTECH (003017.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 910 million yuan, a year-on-year decrease of 1.03%. It realized a net profit attributable to shareholders of the listed company of 63.7463 million yuan, a year-on-year increase of 27.48%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 61.1679 million yuan, a year-on-year increase of 5.94%. The basic earnings per share were 0.7822 yuan. It plans to distribute a cash dividend of 3.00 yuan (tax included) for every 10 shares to all shareholders